Protective effects of citicoline on TNBS-induced experimental colitis in rats

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 4, 2014, Pages 989-997

  Ek, Rauf Onur ^a   Serter, Mukadder ^a   Ergin, Kemal ^a   Cecen, Serpil ^b   Unsal, Cengiz ^a   Yildiz, Yuksel ^a   Bilgin, Mehmet D ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Antioxidant system; Citicoline; Inflammatory bowel disease; TNBS

Indexed keywords

CITICOLINE; GLUTATHIONE; INTERLEUKIN 6; MALONALDEHYDE; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL INFILTRATION; CLINICAL ASSESSMENT; COLITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFLAMMATORY BOWEL DISEASE; HISTOLOGY; HISTOPATHOLOGY; MALE; MICROSCOPY; MUCOSAL BLEEDING; NONHUMAN; RAT;

EID: 84900462428     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Loftus EV. Clinical epidemiology of inflammatory bower disease: incidence, prevalence, and environmental, influences. Gastroenterology 2004; 126: 1504-1517.
2. Katz JA, Itoh J, Fiocchi C. Pathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol 1999; 15: 291-297.
3. Kucharzik T, Maaser C, Lügering A, Kagnoff M, Mayer L, Targan S, Domschke W. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis 2008; 12: 1068-1083.
4. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman GS, Katz S, Floyd RA, McKinley MJ, Fisher SE, Mullin GE. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996; 41: 2078-2086.
5. Kruidenier L, Kuiper I, Van Duijn W, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Verspaget HW. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 2003; 201: 17-27.
6. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994; 344: 859-861.
7. Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 1991; 101: 540-547.
8. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
9. Neurath M, Fuss I, Strober W. TNBS-colitis. Int Rev Immunol 2000; 19: 51-62.
10. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920.
11. Ehehalt R, Jochims C, Lehmann WD, Erben G, Staffer S, Reininger C, Stremmel W. Evidence of luminal phosphatidylcholine secretion in rat ileum. Biochim Biophys Acta 2004; 1682: 63-71.
12. Braun A, Treede I, Gotthardt D, Tietje A, Zahn A, Ruhwald R, Schoenfeld U, Welsch T, Kienle P, Erben G, Lehmann WD, Fuellekrug J, Stremmel W, Ehehalt R. Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis; a clue to pathogenesis. Inflamm Bowel Dis 2009; 15: 1705-1720.
13. Ehehalt R, Wagenblast J, Erben G, Lehmann WD, Hinz U, Merle U, Stremmel W. Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nano electrospray-tandem mass spectrometry. Scand J Gastroenterol 2004; 39: 737-742.
14. Stremmel W, Ehehalt R, Staffer S, Stoffels S, Mohr A, Karner M, Braun A. Mucosal protection by phosphatidylcholine. Dig Dis 2012; 30. 85-91.
15. Stremmel W. Mucosal protection by phosphatidylcholine as new therapeutic concept in ulcerative colitis. Z Gastroenterol 2013; 51: 384-389.
16. Kennedy EP, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipids. J Biol Chem 1956; 222: 193-214.
17. Wurtman RJ, Regan M, Ulus I, Yu L. Effect of oral CDP-choline on plasma choline and urine levels in humans. Biochem Pharmacol 2000; 60: 989-992.
18. Cansev M, Yilmaz MS, Ilcol YO, Hamurtekin E, Ulus IH. Cardiovascular effects of CDP-choline and its metabolites; involvement of peripheral autonomic nervous system. Eur J Pharmacol 2007; 577: 129-142.
19. Wurtman RJ, Cansev M, Ulus IH. Choline and its products acetylcholine and phosphatidylcholine. Berlin: Springer-Verlag; 2009.
20. Lopez-Coviella I, Agut J, Savci V, Ortiz JA, Wurtman RJ. Evidence that 5'-cytidinediphosphocholine can affect brain phospholipids composition by increasing choline and cytidine plasma levels. J Nerochem 1995; 65: 889-894.
21. Fiedorowicz M, Makarewicz D, Stanczak-Mrozek K, Grieb P. CDP-choline (citicoline) attenuates damage in a rat model of birth asphyxia. Acta Neurobil Exp 2008; 68: 389-397.
22. Ozay R, Bekar A, Kocaeli H, Karli N, Filiz G, Ulus IH. Citicoline improves functional recovery, promotes nerve regeneration, and reduces postoperative scarring after peripheral nerve surgery in rats. Surgical Neurology 2007; 68: 615-622.
23. Adibhatia RM, Hatcher FJ. Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders. Neurochem Res 2005; 30: 15-23.
24. Cetinkaya M, Cansev M, Cekmez F, Tayman C, Canpolat FE, Kafa IM, Uysal S, Tunc T, Sarici SU. CDP-choline reduces severity of intestinal injury in a neonatal rat model of necrotizing enterocolitis. J Surg Res 2013; 183: 119-128.
25. González R, Rodríguez S, Romay C, Ancheta O, González A, Armesto J, Remirez D, Merino N. Anti-inflammatory activity of phycocyanin extract in acetic acid-induced colitis in rats. Pharmacol Res 1999; 39: 55-59.
26. Gué M, Bonbonne C, Fioramonti J, Moré J, Del Rio-Lachèze C, Coméra C, Buéno L. Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved. Am J Physiol 1997; 272: 84-91.
27. Lowry OH, Risebrough NJ, Farr AL, Randal RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265-270.
28. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983; 132: 345-352.
29. Buege JA, Aust SD. Lactoperoxidase catalyzed lipid peroxidation of microsomal and artificial membranes. Biochem Biophys Acta 1976; 444: 192-201.
30. Fairbanks VF, Klee GG. Biochemical aspects of hematology. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry; 1999. pp: 1642-1710.
31. Babbs CF. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 1992; 13: 169-181.
32. Keshavarzian A, Sedghi S, Kanofsky J, List T, Robinson C, Ibrahim C, Winship D. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 1992; 103: 177-185.
33. Nieto N, Torres MI, Fernández MI, Girón MD, Ríos A, Suárez MD, Gil A. Experimental ulcerative colitis impairs antioxidant defense system in rat intestine. Dig Dis Sci 2000; 45: 1820-1827.
34. McKenzie SJ, Baker MS, Buffington GD, Doe WF. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 1996; 98: 136-141.
35. Grisham MB, Yamada T. Neutrophils, nitrogen oxides, and inflammatory bowel disease. J Clin Invest 1996; 98: 136-141.
36. Secades JJ. Citicholine: pharmacological and clinical review, 2010 update. Rev Neurol 2011; 52: S1-S62
37. Allen A, Leonard AJ, Sellers LA. The mucus barrier. It's role in gastroduodenal mucosal protection. J Clin Gastroenterol 1988; 10: 93-98.
38. Lichtenberger LM. The hydrophobic barrier properties of gastrointestinal mucus. Ann Rev Physiol 1995; 57: 565-583.
39. Treede I, Braun A, Sparla R, Kühnel M, Giese T, Turner JR, Anes E, Kulaksiz H, Füllekrug J, Stremmel W, Griffiths G, Ehehalt R. Anti-inflammatory effects of phosphatidylcholine. J Biol Chem 2007; 282: 27155-27164.
40. Ehehalt R, Braun A, Karner M, Füllekrug J, Stremmel W. Phosphatidylcholine as a constituent in the colonic mucosal barrier- physiological and clinical relevance. Biochim Biophys Acta 2010; 1801: 983-993.
41. Eros G, Kaszaki J, Czobel M, Boros M. Systemic phosphatidylcholine pretreatment protects canine esophagel mucosa during acute experimental biliary reflux. World J Gastroenterol 2006; 12: 271-279.
42. Demirbilek S, Aydin G, Yucesan S, Vural H, Bitiren M. Polyunsaturated phosphatidylcholine lowers collagen deposition in a rat model of corrosive esophageal burn. Eur J Pediatr Surg 2002; 12: 8-12.
43. Stremmel W, Ehehalt R, Autschbach F, Karner M. Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial. Ann Intern Med 2007; 147: 603-610.
44. Islam MS, Murata T, Fujisawa M, Nagasaka R, Ushio H, Bari AM, Hori M, Ozaki H. Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice. Br J Pharmacol 2008; 154: 812-824.
45. Abreu MT. The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr Gastroenterol Rep 2002; 4: 481-489.
46. Stark G. Functional consequences of oxidative membrane damage. J Membr Biol 2005; 205: 1-16.
47. Isozaki Y, Yoshida N, Kuroda M, Takagi T, Handa O, Kokura S, Ichikawa H, Naito Y, Okanoue T, Yoshikawa T. Effect of a novel water-soluble vitamin E derivative as a cure For TNBS induced colitis in rats. Int J Mol Med 2006; 17: 497-502.
48. Colón AL, Madrigal JL, Menchén LA, Moro MA, Lizasoain I, Lorenzo P, Leza JC. Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats. Dig Dis Sci 2004; 49: 1713-1721.
49. Liu X, Wang J. Anti-inflammatory effects of iridoid glycosides fraction of Folium syringae leaves on TNBS-induced colitis in rats. J Ethnopharmacol 2011; 133: 780-787.
50. Isik F, Tunali Akbay T, Yarat A, Genc Z, Pisiriciler R, Caliskan-Ak E, Cetinel S, Altintas A, Sener G. Protective effects of Black Cumin (Nigella sativa) oil on TNBS-induced experimental colitis in rats. Dig Dis Sci 2011; 3: 721-730.
51. Ek RO, Serter M, Ergin K, Yildiz Y, Cecen S, Kavak T, Yenisey C. The effects of Caffeic Acid Phenethyl Ester (CAPE) on TNBS-induced colitis in ovariectomized rats. Dig Dis Sci 2008; 53: 1609-1617.
52. Witaicenis A, Seito LN, Di Stasi LC. Intestinal anti-inflammatory activity of esculetin and 4-methylesculetin in the tribenzensulphonic acid model of rat colitis. Chemico-Biol Interac 2010; 186: 211-218.
53. Sies H. Glutathione and its role in cellular functions. Free Rad Biol Med 1999; 27: 916-921.
54. Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A, Matsumoto T, Yamamura T, Azuma J, Nishimoto N, Yoshizaki K, Shimoyama T, Kishimoto T. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 2004; 126: 989-996.
55. Luo JY, Cao JC, Jiang XL, Cui HF. Effect of low molecular weight heparin rectal suppository on experimental ulcerative colitis in mice. Biomed Pharmacother 2010; 64: 441-445.
56. Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 2000; 6: 21-33.